SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021
2022; BMJ; Volume: 7; Issue: 8 Linguagem: Inglês
10.1136/bmjgh-2022-008793
ISSN2059-7908
AutoresHannah C. Lewis, Harriet Ware, Mairead Whelan, Lorenzo Subissi, Zihan Li, Xiaomeng Ma, Anthony Nardone, Marta Valenciano, Brianna Cheng, Kim C. Noël, Christian Cao, Mercedes Yanes‐Lane, Belinda L. Herring, Ambrose Talisuna, Ngoy Nsenga, Thierno Baldé, David A. Clifton, Maria D. Van Kerkhove, David L. Buckeridge, Niklas Bobrovitz, Joseph Okeibunor, Rahul K. Arora, Isabel Bergeri,
Tópico(s)COVID-19 Clinical Research Studies
ResumoEstimating COVID-19 cumulative incidence in Africa remains problematic due to challenges in contact tracing, routine surveillance systems and laboratory testing capacities and strategies. We undertook a meta-analysis of population-based seroprevalence studies to estimate SARS-CoV-2 seroprevalence in Africa to inform evidence-based decision making on public health and social measures (PHSM) and vaccine strategy.
Referência(s)